• News
  • SAN DIEGO
  • Finance

Allergan tells shareholders to reject Valeant deal

Allergan, the maker of Botox, said Monday that Valeant Pharmaceuticals' hostile takeover bid for the company is “grossly inadequate” and that shareholders should reject it.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!